WO2017118920A1 - Dispositif de coupe avec enclume expansible - Google Patents
Dispositif de coupe avec enclume expansible Download PDFInfo
- Publication number
- WO2017118920A1 WO2017118920A1 PCT/IB2017/050011 IB2017050011W WO2017118920A1 WO 2017118920 A1 WO2017118920 A1 WO 2017118920A1 IB 2017050011 W IB2017050011 W IB 2017050011W WO 2017118920 A1 WO2017118920 A1 WO 2017118920A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anvil
- cutting
- distal
- cutting device
- blade
- Prior art date
Links
- 0 CCCC1=C(C)C1*F Chemical compound CCCC1=C(C)C1*F 0.000 description 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/32053—Punch like cutting instruments, e.g. using a cylindrical or oval knife
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320064—Surgical cutting instruments with tissue or sample retaining means
Definitions
- the present invention generally relates to tissue cutting devices, and particularly to a cutting device with an expandable anvil for cutting holes, for example, in an atrium wall to reduce elevated filling pressure incurred by cardiac dysfunction to an acceptable level that provides adequate left ventricle function, while reducing the left atrium and pulmonary venous pressures below the point where pulmonary congestion occurs.
- Congestive heart failure is a syndrome characterized by left ventricular dysfunction, reduced exercise tolerance, impaired quality of life and dramatically shortened life expectancy. Decreased contractility of the left ventricle leads to reduced cardiac output with consequent systemic arterial and venous vasoconstriction.
- CHF develops generally in the course of months or years, and can be the end stage of chronic hypertension, infarction, angina, or diabetes.
- pharmacological e.g., diuretics
- assist systems e.g., pumps
- surgical treatments e.g., pharmacological treatments
- diuretics have been used to reduce the workload of the heart by reducing blood volume and preload.
- Assist devices used to treat CHF include, for example, mechanical pumps.
- Mechanical pumps reduce the load on the heart by performing all or part of the pumping function normally done by the heart.
- mechanical pumps are used to sustain the patient while a donor heart for transplantation becomes available for the patient.
- pacing devices used to treat CHF.
- high rate pacing may lead to increased diastolic pressure, indicating calcium overload and damage of the muscle fibers.
- a conduit may be positioned in a hole in the atrial septum of the heart to allow flow from the left atrium into the right atrium. Shunting the blood may reduce left atrial pressures, thereby preventing pulmonary edema and progressive left ventricular dysfunction, and reducing LVEDP.
- A) Use the Seldinger technique to puncture the tissue with a needle, and then use several dilators to increase the puncture size. Balloons may also be used to increase the orifice diameter. Since no tissue is removed, the Seldinger method is used to insert catheters for short percutaneous heart treatment like RF ablation, or to open a blood path between the heart atriums when leaving an implant to keep the orifice open, as such unobstructed orifice/hole will close very quickly as the tissue elasticity tends to regain its original shape.
- the present invention seeks to provide devices and methods for reducing elevated filling pressure, e.g., incurred by cardiac dysfunction, to acceptable levels, while still providing adequate left ventricle function, and reducing the left atrium and pulmonary venous pressures below the point where pulmonary congestion occurs.
- elevated filling pressure e.g., incurred by cardiac dysfunction
- the invention may be applicable to treat several disorders, such as without limitation, increased left atrium pressure (LAP) that occurs as part of Congestive Heart Failure (CHF).
- LAP left atrium pressure
- CHF Congestive Heart Failure
- a device and method are provided for cutting an orifice in the atrium wall between the right and left atriums, preferably at the fossa-ovalis section of the atrial wall.
- Such a large orifice reduces elevated left atrium pressure by allowing blood flow directly from the left atrium into the right atrium.
- a catheter-based device is used to mechanically cut an orifice in the atrial septum wall and remove the cut tissue in one piece from the septum wall (and afterwards out from the body).
- the orifice cutting catheter may cut a large orifice from the atrium septum wall in one catheter activation. The cut tissue is locked inside the catheter and removed from the body when removing the catheter.
- the orifice cutting catheter of the invention may be adjustable to cut different orifice diameters.
- the cutting mechanism may include a specially shaped blade or other hand activated mechanical cutting mechanism.
- the blade may be round (e.g., circular) and may move relative to an anvil or anvils.
- the catheter distal anvil is preferably an expandable anvil.
- This distal anvil may pass the atrial septum through a small diameter puncture, and then expand to its full size (full diameter) to fit the cutting mechanism diameter.
- the diameter of the temporary hole created is unknown at the time the device of the invention is used, usually shortly after the puncture is performed, as the hole created by the sheath or balloon may still be completely or partially open at the time of septum cutting by the catheter of the invention, so it might cut nothing or just small portion of the septum tissue, instead of a full round tissue disk as required.
- the orifice is preferably cut in a smooth, round shape, without any jagged edges or bulges that might disturb blood flow.
- the round cutting blade may be connected to an RF energy source, using the round blade as an RF electrode, to allow cutting a round large opening in the atrial septum.
- the orifice cutting catheter of the invention may be coated with substances, such as but not limited to, Paclitaxel drug used in drug eluting balloons, to prevent cell growth at the edges of the orifice.
- substances such as but not limited to, Paclitaxel drug used in drug eluting balloons, to prevent cell growth at the edges of the orifice.
- the present invention describes, inter alia, methods and apparatus for decreasing pressure in the left side of the cardiac structure of a patient by opening an orifice or a shunt communicating with an area on both left and right sides of the heart atriums, whereby a volume of blood sufficient to reduce pressure in the left atrium is released from one atrium to the other.
- Fig. 1 is a schematic illustration of the heart chambers and the atrial septum.
- Fig. 2 is a schematic illustration of a cutting device in accordance with a non- limiting embodiment of the present invention, with a distal anvil penetrating the atrial septum.
- Fig. 3 is a sectional schematic illustration of heart chambers with a hole in the atrial septum made with the device of the invention.
- Fig. 4 is a simplified illustration of the device of the invention with a proximal handle, control knobs and a distal balloon-expandable anvil.
- Fig. 5 is a further illustration of the device of the invention with a balloon- expandable anvil.
- Fig. 6 is a simplified schematic illustration of the device of the invention after penetrating the atrial septum, before opening the balloon anvil.
- Fig. 7 is a simplified schematic illustration of the device of the invention after penetrating the atrial septum, opening the balloon-expandable anvil, and pulling the balloon backwards towards the septum.
- Fig. 8 is a simplified schematic illustration of locking the septum tissue between the two anvils.
- Fig. 9 is a simplified sectional schematic illustration of the device of the invention after cutting the hole in the atrial septum, keeping the cut tissue within the catheter tip.
- Fig. 10 is a simplified sectional schematic illustration of the device of the invention, in accordance with another non-limiting embodiment of the present invention, having a self-expandable distal anvil (e.g., made from a shape memory material) in its contracted, non-expanded position.
- a self-expandable distal anvil e.g., made from a shape memory material
- Fig. 11 is a simplified sectional schematic illustration of the device of Fig. 10, with the self-expandable distal anvil in its expanded position.
- FIG. 1 illustrates pertinent parts of the cardiovascular anatomy. Shown are a large peripheral vein 9 next to the right atrium 5, and the atrial septum 4 that separates the right atrium 5 from the left atrium 6.
- Cutting device 1 which may be delivered over a guidewire 2, includes a cutting assembly 33, which may be located at a distal portion 31 of a working shaft 34.
- a distal anvil 32 is located distally of cutting assembly 33 on an anvil shaft 39.
- a proximal anvil 42 is located near cutting assembly 33. In one embodiment, proximal anvil 42 is arranged to be concentric with, and moved inwards of, cutting assembly 33.
- the device 1 may be delivered to the right atrium 5 by passing over guidewire 2.
- the guidewire 2 passes from the right atrium 5 through the atrial septum 4 into the left atrium 6.
- the distal anvil 32 while in the contracted orientation, passes into the left atrium 6 through the opening formed in the septum 4 by guidewire 2.
- the distal anvil 32 is then expanded.
- the proximal anvil 42 and the distal anvil 32 are brought towards each other so as to clamp septum 4. While the septum 4 is clamped, cutting assembly 33 may then be used to cut an aperture 7 (Fig. 3) in septum 4.
- Cutting device 1 may include a proximal handle 35 with one or more control knobs 40 and 41.
- a flexible shaft 34 extends distally from handle 35.
- the cutting assembly 33 may be located at distal portion 31 of shaft 34.
- Distal anvil 32 is located distally of cutting assembly 33 on anvil shaft 39.
- a guidewire lumen 37 may extend distally of distal anvil 32.
- FIG. 6 illustrates one application of cutting device 1, namely, to cut an aperture in the atrial septum 4 (e.g., at or near the fossa ovalis 8, to allow blood to flow through the aperture between the left and right atriums.
- This helps reduce elevated filling pressure incurred by cardiac dysfunction, to an acceptable level that provides adequate left ventricle function, while reducing the left atrium and pulmonary venous pressures below the point where pulmonary congestion occurs.
- Cutting device 1 may be delivered to the right atrium by passing over guidewire 2.
- the guidewire 2 passes from the right atrium through the atrial septum 4 into the left atrium.
- the distal anvil 32 while in the contracted orientation and mounted on anvil shaft 39, passes into the left atrium through the opening formed in the septum 4 by guidewire 2.
- the proximal anvil 42 is on the proximal side of the septum 4 in the right atrium.
- the distal anvil 32 is then expanded, such as by expanding a balloon, next to or connected to, distal anvil 32.
- the portion of anvil 32 which expands is designated in the drawings by numeral 38.
- the balloon may form part of or all of distal anchor 32.
- the balloon may be expanded by introducing fluid thereto, as is well known in the art.
- proximal anvil 42 and the distal anvil 32 are brought towards each other so as to clamp septum 4.
- the atrium fossa tissue is very thin and flexible, and moves as the heart beats. Therefore in order to cut the aperture, the atrium fossa must be held tight. On the other hand, it is dangerous to apply uncontrolled pressure on the tissue as it may tear completely or in an uncontrolled shape.
- the invention solves these problems by the clamping action of the two anvils.
- proximal anvil 42 is arranged to be concentric with blade 36 of cutting assembly 33.
- the cutting assembly may be moved over proximal anvil 42.
- the rotating round blade 36 may have a uniform, sharp cutting edge, or multiple cutting teeth.
- Blade 36 may move relative to distal and proximal anvils 32 and 42 to cleanly cut a circular hole in the atrial septum 4.
- the blade may be moved manually, semi-automatically or automatically by the control button or buttons. In the automatic mode, a motor or other suitable actuator may be used to rotate blade 36.
- the cut hole perimeter is free of burrs and ragged edges.
- the cut material is entrapped between the two anvils and covered by cutting assembly 33, so that no dangerous debris is left to flow in the vasculature.
- the cut material is removed from the body upon removal of the device from the body.
- the cut aperture size may be a few millimeters in diameter, in the range between 2 mm to 10 mm, and more preferably between 5-8 mm in diameter.
- the aperture is not limited in size or shape (e.g., may be oval or non-round).
- blade 36 may be connected to an RF energy source 50 (Fig. 4) so that blade 36 serves as an electrode to cut the tissue by RF ablation.
- the tissue may vaporize during ablation, minimizing risk of debris entering the vasculature.
- the RF ablation/cutting may be combined with mechanical cutting of the blade or other blade.
- the blade may operate in bipolar, monopolar or combined monopolar and bipolar mode.
- the distal anchor 32 may include a flexible conductive ring 44 printed at its proximal base, as known in the art for electrodes printing over balloons used in ablation catheters. Flexible ring 44 may be connected to the second pole of the bipolar RF energy source 50, while blade 36 (in the form of a ring) may be connected to the first lead of the bipolar RF energy RF energy source 50.
- the distal anchor 32 and the blade 36 may operate as bipolar electrodes.
- a distal self-expandable anvil 52 is made from a shape memory material (e.g., nitinol), such as from wires or wire mesh 51.
- the self-expandable anvil 52 may be initially collapsed inside anvil shaft 39 while penetrating through the atrial septum. After passing from the right atrium into the left atrium, the wires 51 may be deployed and expanded out the shaft 29 to regain the shape of the distal anchor 52 as seen in Fig. 11. The device is then used as described before.
- the cutting blades 36 and anvils 32 and/or 42 may be coated with drugs (e.g., Paclitaxel) used in drug eluting balloons, to prevent cell growth at the edges of the orifice.
- drugs e.g., Paclitaxel
- the working shaft 34 may have a pre- bended tip or deflected tip mechanism using a pulling wire or other bending mechanism, in order to aim the distal tip 31 of device towards the atrial septum.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Un dispositif de coupe (1) comprend un ensemble de coupe (33) situé sur un arbre de travail (34) et en communication fonctionnelle avec une poignée (35). Une enclume expansible distale (32) et une enclume proximale (42) sont situées de manière amovible sur un arbre d'enclume (39) qui s'étend de façon distale de l'arbre de travail (34). L'enclume distale (32) et l'enclume proximale (42) peuvent être rapprochées et écartées l'une de l'autre. L'ensemble de coupe (33) comprend une lame de coupe (36) opérationnelle pour découper le tissu clampé entre l'enclume distale (32) et l'enclume proximale (42).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662274433P | 2016-01-04 | 2016-01-04 | |
US62/274,433 | 2016-01-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017118920A1 true WO2017118920A1 (fr) | 2017-07-13 |
Family
ID=58191496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2017/050011 WO2017118920A1 (fr) | 2016-01-04 | 2017-01-03 | Dispositif de coupe avec enclume expansible |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017118920A1 (fr) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10828151B2 (en) | 2009-05-04 | 2020-11-10 | V-Wave Ltd. | Devices for reducing left atrial pressure, and methods of making and using same |
US10898698B1 (en) | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US10912645B2 (en) | 2004-02-03 | 2021-02-09 | V-Wave Ltd. | Device and method for controlling in-vivo pressure |
US10925706B2 (en) | 2009-05-04 | 2021-02-23 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US10940296B2 (en) | 2015-05-07 | 2021-03-09 | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | Temporary interatrial shunts |
US11109988B2 (en) | 2016-05-31 | 2021-09-07 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
US11253353B2 (en) | 2006-01-23 | 2022-02-22 | V-Wave Ltd. | Heart anchor device |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
US11304753B2 (en) | 2019-09-13 | 2022-04-19 | Alleviant Medical, Inc. | Systems, devices, and methods for forming an anastomosis |
US11304831B2 (en) | 2016-05-31 | 2022-04-19 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
US11690976B2 (en) | 2013-05-21 | 2023-07-04 | V-Wave Ltd. | Apparatus and methods for delivering devices for reducing left atrial pressure |
US11744589B2 (en) | 2018-01-20 | 2023-09-05 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
US11813386B2 (en) | 2022-04-14 | 2023-11-14 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
US11850138B2 (en) | 2009-05-04 | 2023-12-26 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US11865282B2 (en) | 2019-05-20 | 2024-01-09 | V-Wave Ltd. | Systems and methods for creating an interatrial shunt |
US12005214B2 (en) | 2009-05-04 | 2024-06-11 | V-Wave Ltd. | Device and method for regulating pressure in a heart chamber |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130006281A1 (en) * | 1999-04-05 | 2013-01-03 | Medtronic, Inc. | Apparatus and Methods for Anastomosis |
US20140081305A1 (en) * | 2012-09-06 | 2014-03-20 | Indian Wells Medical, Inc. | Hollow Organ Coring Tool with Collapsing Anvil and Method of Use |
US20140228843A1 (en) * | 2009-04-06 | 2014-08-14 | Michael J. O'Donnell | System and method for resecting a valve |
US20140277045A1 (en) * | 2013-03-12 | 2014-09-18 | Dc Devices, Inc. | Devices, systems, and methods for treating heart failure |
US20150359556A1 (en) * | 2014-06-13 | 2015-12-17 | InterShunt Technologies, Inc. | Method and catheter for creating an interatrial aperture |
-
2017
- 2017-01-03 WO PCT/IB2017/050011 patent/WO2017118920A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130006281A1 (en) * | 1999-04-05 | 2013-01-03 | Medtronic, Inc. | Apparatus and Methods for Anastomosis |
US20140228843A1 (en) * | 2009-04-06 | 2014-08-14 | Michael J. O'Donnell | System and method for resecting a valve |
US20140081305A1 (en) * | 2012-09-06 | 2014-03-20 | Indian Wells Medical, Inc. | Hollow Organ Coring Tool with Collapsing Anvil and Method of Use |
US20140277045A1 (en) * | 2013-03-12 | 2014-09-18 | Dc Devices, Inc. | Devices, systems, and methods for treating heart failure |
US20150359556A1 (en) * | 2014-06-13 | 2015-12-17 | InterShunt Technologies, Inc. | Method and catheter for creating an interatrial aperture |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10912645B2 (en) | 2004-02-03 | 2021-02-09 | V-Wave Ltd. | Device and method for controlling in-vivo pressure |
US11266501B2 (en) | 2004-02-03 | 2022-03-08 | V-Wave Ltd. | Device and method for controlling in-vivo pressure |
US11382747B2 (en) | 2004-02-03 | 2022-07-12 | V-Wave, Ltd. | Device and method for controlling in-vivo pressure |
US11253353B2 (en) | 2006-01-23 | 2022-02-22 | V-Wave Ltd. | Heart anchor device |
US10828151B2 (en) | 2009-05-04 | 2020-11-10 | V-Wave Ltd. | Devices for reducing left atrial pressure, and methods of making and using same |
US12005214B2 (en) | 2009-05-04 | 2024-06-11 | V-Wave Ltd. | Device and method for regulating pressure in a heart chamber |
US10925706B2 (en) | 2009-05-04 | 2021-02-23 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US11850138B2 (en) | 2009-05-04 | 2023-12-26 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
US11690976B2 (en) | 2013-05-21 | 2023-07-04 | V-Wave Ltd. | Apparatus and methods for delivering devices for reducing left atrial pressure |
US10940296B2 (en) | 2015-05-07 | 2021-03-09 | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | Temporary interatrial shunts |
US11304831B2 (en) | 2016-05-31 | 2022-04-19 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US11497631B2 (en) | 2016-05-31 | 2022-11-15 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US11607327B2 (en) | 2016-05-31 | 2023-03-21 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US11109988B2 (en) | 2016-05-31 | 2021-09-07 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
US11744589B2 (en) | 2018-01-20 | 2023-09-05 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
US11865282B2 (en) | 2019-05-20 | 2024-01-09 | V-Wave Ltd. | Systems and methods for creating an interatrial shunt |
US11304753B2 (en) | 2019-09-13 | 2022-04-19 | Alleviant Medical, Inc. | Systems, devices, and methods for forming an anastomosis |
US11612432B2 (en) | 2019-09-13 | 2023-03-28 | Alleviant Medical, Inc. | Systems, devices, and methods for forming an anastomosis |
US11871987B2 (en) | 2019-09-13 | 2024-01-16 | Alleviant Medical, Inc. | Systems, devices, and methods for forming an anastomosis |
US10898698B1 (en) | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
US11813386B2 (en) | 2022-04-14 | 2023-11-14 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017118920A1 (fr) | Dispositif de coupe avec enclume expansible | |
CN110494183B (zh) | 用于心房间吻合术的经导管装置 | |
US11957374B2 (en) | Method and catheter for creating an interatrial aperture | |
US10993735B2 (en) | Method and catheter for creating an interatrial aperture | |
US11369405B2 (en) | Method and septostomy device for creating an interatrial aperture | |
EP3641677B1 (fr) | Dispositifs et systèmes de fenêtrage | |
US9775636B2 (en) | Devices, systems, and methods for treating heart failure | |
JP4504349B2 (ja) | カッティング装置及び狭窄の切開装置 | |
US9332993B2 (en) | Devices and methods for delivering an endocardial device | |
JPH10512163A (ja) | 心筋保護下の心停止を誘発するための逆行送込みカテーテルと方法 | |
US8308723B2 (en) | Tissue-penetrating guidewires with shaped tips, and associated systems and methods | |
CN110022779B (zh) | 经中隔***装置 | |
EP4054448A1 (fr) | Procédé et dispositif de septostomie pour créer une ouverture interauriculaire | |
US20180263658A1 (en) | Expandable Cardiac Access Catheter | |
US20100160939A1 (en) | Systems, apparatuses, and methods for cardiovascular cutting devices and valves | |
JP2023544075A (ja) | 肺動脈性肺高血圧症用カテーテル | |
US20230181214A1 (en) | Method and septostomy device for creating an interatrial aperture | |
US20240206902A1 (en) | Pulmonary arterial hypertension catheters | |
WO2022225721A1 (fr) | Système de cathéter d'excision pour une valve aortique | |
JP2024502267A (ja) | 中隔パンチ並びに治療器具の送達及び操縦のための装置及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17707949 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 30.10.2018) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17707949 Country of ref document: EP Kind code of ref document: A1 |